©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 111164
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.111164
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.111164
Table 4 Vasoactive drugs
| Ref. | NE dosage | TP dosage | Vasopressin dosage | Dobutamine dosage |
| Lyu et al[15], 2022 | Not specified | |||
| Ibarra-Estrada et al[16], 2023 | Not specified | 0.03 IU/minute if NE dose reached ≥ 0.25 μg/kg/minute | ||
| Hajjar et al[17], 2019 | Infusion was started at 5 mL/hours and increased by 2.5 mL/hours every 10 minutes to reach a maximum target rate of 30 mL/hours | Ranged from 0.01 to 0.06, IU/minute | ||
| Moskowitz et al[18], 2020 | Not specified | |||
| Fujii et al[19], 2020 | Initial dose: 0.05 to 0.5 μg/kg/minute, Titration: Dose adjusted based on the patient's blood pressure response, aiming to maintain a MAP ≥ 65 mmHg | |||
| Sevransky et al[20], 2021 | Initial dose: Start at 0.05 to 0.1 μg/kg/minute. Titration: Adjust as necessary to achieve a MAP ≥ 65 mmHg | |||
| Wang et al[21], 2022 | NE greater than or equal to 15 μg/minute (Norepinephrine ≥ 15 μg/minute) | |||
| Cherukuri et al[22], 2019 | Not specified | |||
| Douglas et al[23], 2020 | Initial dose: 0.05 to 0.1 μg/kg/minute; Titration: Dose increased based on the patient's response, often up to 0.5 μg/kg/minute or higher if necessary to achieve and maintain a MAP of ≥ 65 mmHg | |||
| Morelli et al[24], 2008 | Continuous infusion: 0.9 mg/kg/minute to maintain MAP (MAP) at 70 mmHg | Single dose: 1 mg administered as a bolus infusion | Initial dose: 3 mg/kg/minute. Titration: The dose was progressively increased in increments of 1 to 3 mg/kg/minute to reverse the anticipated decrease in mixed SvO2 caused by the infusion of TP | |
| Albanèse et al[25], 2005 | Initial Dose: 0.3 μg/kg/minute. Titration: Increased by increments of 0.3 μg/kg/minute at 4-minute intervals to achieve a target MAP of 65 to 75 mmHg | Initial bolus: 1 mg (equivalent to 0.03-0.04 UI/minute). Second bolus: An additional 1 mg was given if the MAP remained below 65 mmHg after 20 minutes | ||
| Hyvernat et al[26], 2016 | Initial dosage: The starting dose typically ranged from 0.05 to 0.5 μg/kg/minute and was titrated based on the patient's response. Titration: Doses were adjusted as needed to achieve the target MAP | |||
| Annane et al[27], 2002 | Systolic arterial pressure lower than 90 mmHg for at least 1 hours despite adequate fluid replacement and administration of more than 5 μg/kg of dopamine, or current treatment with epinephrine or NE | |||
| Morelli et al[35], 2009 | NE 15 μg/minute | Terlipressin 1.3 μg/kg/hour | Vasopressina 0.03 U/minute | |
| Lv et al[36], 2017 | Not specified | |||
| Russell et al[32], 2008 | 5 μg of NE per minute | |||
| Russell et al[31], 2009 | 5 μg of NE per minute | |||
| Venkatesh et al[33], 2019 | Not specified | |||
| Yildiz et al[37], 2011 | Not specified | |||
| Keh et al[30], 2003 | Not specified | |||
| Keh et al[38], 2016 | Not specified | |||
| Annane et al[34], 2018 | 0.5 to 1.0 µg/kg/minute to maintain MAP | |||
| Liu et al[28], 2018 | starting dose of 4 µg/min, which could be titrated up to a maximum of 30 µg/minute | 20 µg/hour, with the option to titrate up to a maximum of 160 µg/hour | ||
| Xiao et al[29], 2016 | From 0.5 to 2.22 µg/kg/minute to maintain MAP | 1.3 mg/kg/hour |
- Citation: Nacul FE, Bezerra MB, Gomes BC, Hohmann FB, Treml RE, Caldonazo T, da Silva AA, Passos RH, de Oliveira NE, Bedretchuk GP, Silva Jr JM. Current and emerging therapeutic options for refractory septic shock: A systematic review. World J Crit Care Med 2025; 14(4): 111164
- URL: https://www.wjgnet.com/2220-3141/full/v14/i4/111164.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.111164